ロード中...
Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
Drug induced liver injury (DILI) is a potentially serious adverse reaction in a few susceptible individuals under therapy by various drugs. Health care professionals facing DILI are confronted with a wealth of drug-unrelated liver diseases with high incidence and prevalence rates, which can confound...
保存先:
| 出版年: | Int J Mol Sci |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5412387/ https://ncbi.nlm.nih.gov/pubmed/28398242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18040803 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|